Hepatocellular Carcinoma Update
First-Line Therapy for Metastatic Non-Small Cell Lung Cancer and an ALK Rearrangement — An Interview with Dr Justin F Gainor
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:57:28
- Mais informações
Informações:
Sinopse
Dr Justin F Gainor from Massachusetts General Hospital in Boston reviews available clinical data on ALK inhibitors and first-line treatment strategies for ALK-positive metastatic non-small cell lung cancer. CME information and select publications here.
